Related Experiment Video
Updated: Jun 25, 2026
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Targeting exofacial protein thiols with Gd(III) complexes. An efficient procedure for MRI cell labelling
Giuseppe Digilio1, Valeria Catanzaro, Franco Fedeli
1Department of Environmental and Life Sciences, University of Eastern Piedmont "A. Avogadro", Via Bellni 25G, 15100 Alessandria, Italy. giuseppe.digilio@mfn.unipmn.it
Chemical Communications (Cambridge, England)
|February 14, 2009
Summary
Researchers developed novel Gadolinium (Gd(III))-based contrast agents for Magnetic Resonance Imaging (MRI) to track cells. These agents target protein thiols on the cell surface, enabling reversible labeling for enhanced cell tracking applications.
Area of Science:
- Biomedical Imaging
- Cell Biology
- Radiochemistry
Background:
- The plasma membrane of cells possesses abundant protein thiols.
- Current cell tracking methods have limitations in resolution and reversibility.
Purpose of the Study:
- To develop novel Gadolinium (Gd(III))-based contrast agents for Magnetic Resonance Imaging (MRI).
- To enable reversible labeling of cell surface protein thiols for effective cell tracking.
Main Methods:
- Design and synthesis of specific Gd(III)-based contrast agents.
- Application of agents to label protein thiols on the cell surface.
- Evaluation of labeling reversibility and suitability for MRI cell tracking.
Main Results:
- Successfully developed Gd(III)-based contrast agents capable of targeting protein thiols.
- Demonstrated reversible labeling of cell surface protein thiols.
- Confirmed the utility of these agents for cell tracking via MRI.
Conclusions:
- Gd(III)-based contrast agents offer a promising approach for reversible cell surface labeling.
- This method facilitates effective cell tracking using MRI, advancing biomedical imaging techniques.
